sNDA

Roche seeks new Lucentis indication

Roche seeks new Lucentis indication

By

The company is seeking a diabetic retinopathy indication.

Company news: Par Pharmaceutical; Gilead

By

Par Pharmaceutical is going private, selling to TPG for $1.9 billion in cash.

Email Newsletters

MM&M inVISION